Russia’s mRNA Cancer Vaccine “Enteromix” Shows 100% Success in Early Trials — A New Era in Personalized Cancer Treatment
In a groundbreaking development that could reshape the future of oncology, Russian scientists have unveiled Enteromix, a new mRNA-based cancer vaccine that has shown 100% efficacy and safety in early-stage human trials. Developed by the National Medical Research Radiological Centre in collaboration with the Engelhardt Institute of Molecular Biology, Enteromix represents a major leap in […]